Therapeutics News

Whether determining what to prescribe a patient or interpreting a symptom, it is imperative for optometrists to be knowledgeable of not only the possible ocular side effects of oral agents, but also the systemic environment of the patient.

The Optometry Board of Australia revised the Guidelines for Use of Scheduled Medicines to include antiglaucoma agents, according to a press release from the board.

The Optometry Board of Australia revised the Guidelines for Use of Scheduled Medicines to include antiglaucoma agents, according to a press release from the board.

NEW YORK — Doctors must consider all possible factors when attempting to treat a patient with allergic conjunctivitis because not all allergies are the same, a speaker said here at Vision Expo East.

ATLANTA — Methicillin-resistant Staphylococcus aureus is still the infectious bacteria optometrists – and all of health care – need to fear, and likely the only answer for it lies in genetics and molecular biology, according to a speaker here at SECO.

ATLANTA – More optometrists will be using injectable medications for diagnostic and therapeutic primary eye care as privileges expand, a lecturer said here at the SECO meeting.

ATLANTA — When making the decision to use steroids to treat inflammation, optometrists should prescribe an aggressive dosing frequency, according to a lecturer here at SECO.

ATLANTA – Because patients’ individual needs and wants vary, doctors need to be well educated on both branded products and generics so they can tailor treatment, according to a lecturer here at SECO.

PHOENIX – Treatment with bepotastine 1.5% solution for allergic conjunctivitis was shown to relieve allergic rhinitis symptoms as well, according to a case report presented in a poster here at Academy 2012.

PHILADELPHIA — Eye drops made from blood serum improved symptoms of ocular surface disease and improved patients’ quality of life, according to a study presented here.